PDE5A and pulmonary arterial hypertension: A significant amount of PDE5 is present in the lung tissue, and inhibiting PDE5 leads to a decrease in pulmonary vascular resistance both in experimental models and also in patients with HF and pulmonary hypertension.48, 49, 50